Our study identified circulating IL-34 from HBV-HCC patients was significantly higher than that of CHB, HBV-cirrhosis and HCs, suggesting that IL-34 may contribute to tumorigenesis of HCC, enhancing progression from CHB patients to cirrhosis, and finally HCC. This evidence concerns the gene IL34 and hepatocellular carcinoma.